top of page
about prostate cancer
early detection & screening: The psa test
The primary test for prostate cancer, the PSA blood test, has been controversial and there are currently no guidelines to inform systematic testing.
The debate is due to the fact that all prostate cancers are not the same. Yet the PSA test cannot differentiate between “low-risk” disease that does not threaten life, and “high-risk” disease that is aggressive, will spread, and can be fatal.
Because the majority of prostate cancers are low-risk, past large-scale PSA testing in the general population led to extensive over-treatment of low-risk disease, often with debilitating side effects.
get screened
get involved
support
-
African American Churches in San Francisco
-
Missionary Temple Christian Methodist Episcopal Church
-
St. John Missionary Baptist Church
-
St. Philip Missionary Baptist Church
-
Alameda County Public Health Department Office of Urban Male Health
-
Arthur H. Coleman Community Health Foundation
-
Bayview Hunters Point Clinic at the Arthur H. Coleman Medical Center
-
California Cancer Plan
-
California Urological Association
-
Kaiser Permanente San Francisco
-
San Francisco Department of Public Health
-
Tabernacle Community Development Corporation
-
UCSF Abundant Life Health Ministries Initiative
-
UCSF Health, Primary Care
-
ZERO - The End of Prostate Cancer
partner organizations
bottom of page